CSII News and Press, Cardiovascular Systems Inc. From 11/09/22

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host inve...

Cardiovascular Systems, Inc. (CSII) Q1 2023 Results Conference Call November 03, 2022 09:00 AM ET Company Participants Jack Nielsen - Vice President of Investor Relations Scott Ward - Chairman, President and Chief Executive Officer Jeff Points - Chief Financial O...

Cardiovascular Systems press release ( NASDAQ: CSII ): Q1 GAAP EPS of -$0.27 misses by $0.04 . Revenue of $59.67M (+2.2% Y/Y) beats by $0.33M . Fiscal Year 2023 Guidance: Ward added, “Q1 results were consistent with our expectations. As a result, we ...

Conference Call Scheduled for Today, November 3, 2022, at 8:00 a.m. CT (9:00 a.m. ET) Revenues of $59.7 million increased 2.2% compared to first quarter last year Management reiterates fiscal 23 revenue guidance of $255 million to $265 million, representing 8% to 12%...

Summary JNJ announced the $16.6 billion-plus acquisition of Abiomed, agreeing to pay $380/share in cash upfront and up to $35/share tied to longer-term performance targets. Abiomed sells heart pumps that assist damaged hearts with their core pumping functions, improving survival a...

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today the full market release of the 2.00 Max Crown for Peripheral O...

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) plans to announce its operating results for the quarter ended September 30, 2022 before the market opens on Thursday, November 3, 2022, and will host a conference call at 8:00 a.m. CT (9:00 a.m. ET) that day to discuss those ...

Image source: The Motley Fool. Cardiovascular Systems (NASDAQ: CSII) Q4 2022 Earnings Call Aug 03, 2022 , 10:00 a.m. ET John Nielsen Continue reading For further details see: Cardiovascular Systems (CSII) Q4 2022 Earnings Call Transcript ...

Cardiovascular Systems press release ( NASDAQ: CSII ): Q4 GAAP EPS of -$0.25 misses by $0.03 . Revenue of $62.5M (-12.0% Y/Y) misses by $0.46M . The Adjusted EBITDA loss increased to $4.3M from near breakeven in the prior year. For the fiscal year endin...

Webcast Scheduled for Tomorrow, August 3, 2022, at 9:00 a.m. CT (10:00 a.m. ET) Revenues of $62.5 million increased 11% sequentially compared to third quarter this year and decreased 12% compared to fourth quarter last year Management provides fiscal 23 revenue guida...